Pharma Mar (PHMMF) Short Interest Ratio & Short Volume $92.57 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Pharma Mar Short Interest DataPharma Mar (PHMMF) has a short interest of 4,400 shares. This marks a -49.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 2,471 shares to cover all short positions.Current Short Interest4,400 sharesPrevious Short Interest8,700 sharesChange Vs. Previous Month-49.43%Dollar Volume Sold Short$459.77 thousandShort Interest Ratio0.9 Days to CoverLast Record DateJune 15, 2025Today's Trading Volume2,500 sharesAverage Trading Volume2,471 sharesToday's Volume Vs. Average101% Short Selling Pharma Mar? Sign up to receive the latest short interest report for Pharma Mar and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPHMMF Short Interest Over TimePHMMF Days to Cover Over TimePHMMF Percentage of Float Shorted Over Time Pharma Mar Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20254,400 shares $459.77 thousand -49.4%N/A0.9 $104.49 5/31/20258,700 shares $814.49 thousand -78.0%0.0%87 $93.62 5/15/202539,600 shares $3.20 million No Change0.2%396 $80.91 4/30/202539,600 shares $3.49 million No ChangeN/A198 $88.18 4/15/202539,600 shares $3.49 million +21.1%0.2%396 $88.18 3/31/202532,700 shares $2.88 million +0.6%0.2%16.4 $88.18 3/15/202532,500 shares $3.32 million -0.6%0.2%15.5 $102.08 2/28/202532,700 shares $3.13 million +43.4%0.2%327 $95.79 2/15/202522,800 shares $2.18 million No Change0.1%228 $95.79 1/31/202522,800 shares $2.18 million -81.4%N/A4 $95.79 Get the Latest News and Ratings for PHMMF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025122,400 shares $9.92 million +436.8%N/A20.7 $81.07 12/31/202422,800 shares $1.85 million No ChangeN/A3.1 $81.07 12/15/202422,800 shares $1.85 million -0.9%N/A6.2 $81.07 11/30/202423,000 shares $1.73 million -13.2%N/A230 $75.00 11/15/202426,500 shares $1.99 million -0.4%N/A265 $75.00 10/31/202426,600 shares $2.00 million +116.3%N/A266 $75.00 10/15/202412,300 shares $875.76 thousand -30.9%N/A123 $71.20 9/30/202417,800 shares $961.20 thousand -47.8%N/A178 $54.00 9/15/202434,100 shares $1.56 million No ChangeN/A56.8 $45.85 8/31/202434,100 shares $1.53 million -0.3%N/A341 $44.90 8/15/202434,200 shares $1.17 million -14.3%N/A342 $34.26 7/31/202439,900 shares $1.37 million -16.2%N/A399 $34.26 7/15/202447,600 shares $1.63 million -7.8%N/A476 $34.26 6/30/202451,600 shares $1.82 million -9.0%N/A516 $35.23 6/15/202456,700 shares $1.77 million -11.7%N/A566.7 $31.15 5/31/202464,200 shares $2.00 million -3.2%N/A642 $31.15 5/15/202466,300 shares $2.07 million -6.2%N/A165.8 $31.15 4/30/202470,700 shares $1.90 million -1.0%N/A707 $26.85 4/15/202471,400 shares $1.92 million -0.3%N/A714 $26.85 3/31/202471,600 shares $2.10 million +3.8%N/A716 $29.29 3/15/202469,000 shares $2.10 million +4.6%N/A345 $30.38 2/29/202466,000 shares $2.30 million -3.7%N/A110 $34.90 2/15/202468,500 shares $3.02 million No ChangeN/A685 $44.13 1/15/202490,600 shares $3.92 million +38.7%N/A906 $43.28 12/31/202365,300 shares $3.02 million -2.3%N/A1087.6 $46.26 12/15/202366,800 shares $3.09 million +0.8%N/A133.6 $46.26 11/30/202366,300 shares $2.37 million No ChangeN/A663 $35.81 11/15/202366,300 shares $2.37 million -0.2%N/A165.8 $35.81 10/31/202366,400 shares $2.13 million +0.2%N/A664 $32.10 10/15/202366,300 shares $2.13 million No ChangeN/A663 $32.10Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 9/30/202366,300 shares $2.21 million No ChangeN/A663 $33.34 9/15/202366,300 shares $2.29 million -0.2%N/A663 $34.47 8/31/202366,400 shares $2.56 million -48.4%N/A587.2 $38.51 8/15/2023128,600 shares $4.59 million +0.9%N/A643 $35.70 7/31/2023127,400 shares $4.51 million No ChangeN/A424.7 $35.43 7/15/2023127,400 shares $4.71 million -2.0%N/A212.3 $36.97 6/30/2023130,000 shares $4.68 million -0.1%N/A1300 $36.03 6/15/2023130,100 shares $4.94 million +0.9%N/A650.5 $37.96 5/31/2023128,900 shares $4.40 million -2.4%N/A1289 $34.12 5/15/2023132,100 shares $5.44 million +4.1%N/A1321 $41.21 4/30/2023126,900 shares $5.69 million No ChangeN/A1269 $44.87 4/15/2023126,900 shares $5.76 million -0.1%N/A634.5 $45.39 3/31/2023127,000 shares $6.06 million No ChangeN/A1270 $47.70 3/15/2023127,000 shares $8.81 million +33.0%N/A1270 $69.40 2/28/202395,500 shares $6.63 million +140.6%N/A955 $69.40 2/15/202339,700 shares $2.76 million -36.6%N/A397 $69.40 1/31/202362,600 shares $4.29 million +6.8%N/A626 $68.50 1/15/202358,600 shares $4.01 million -10.5%N/A586 $68.50 12/30/202265,500 shares $4.54 million -10.8%N/A655 $69.39 12/15/202273,400 shares $5.09 million -10.2%N/A367 $69.39 11/30/202281,700 shares $5.73 million -0.4%N/A26.4 $70.17 11/15/202282,000 shares $5.47 million +0.4%N/A820 $66.68 10/31/202281,700 shares $4.46 million +55.9%N/A817 $54.60 10/15/202252,400 shares $2.99 million -5.1%N/A524 $57.00 9/30/202255,200 shares $2.91 million +1.5%N/A276 $52.80 9/15/202254,400 shares $3.10 million +56.3%N/A544 $56.96 8/31/202234,800 shares $2.20 million -8.9%N/A348 $63.29 8/15/202238,200 shares $2.42 million +17.5%N/A191 $63.29 7/31/202232,500 shares $2.44 million +0.3%N/A162.5 $75.00 7/15/202232,400 shares $2.47 million -8.7%N/A324 $76.34 6/30/202235,500 shares $2.71 million +1,083.3%N/A355 $76.34 6/15/20223,000 shares $229.02 thousand -28.6%N/A30 $76.34 5/31/20224,200 shares $319.20 thousand +40.0%N/A42 $76.00 5/15/20223,000 shares $231 thousand +1,400.0%N/A30 $77.00 4/30/2022200 shares $15.40 thousand -86.7%N/A2 $77.00 4/15/20221,500 shares $115.50 thousand +200.0%N/A15 $77.00 3/31/2022500 shares $38.50 thousand No ChangeN/A5 $77.00 3/15/2022500 shares $30.23 thousand No ChangeN/A5 $60.46 2/28/2022500 shares $27.74 thousand No ChangeN/A1.7 $55.47 2/15/2022500 shares $30.50 thousand -28.6%N/A2.5 $61.00 1/31/2022700 shares $43.09 thousand No ChangeN/A1.2 $61.56 1/15/2022700 shares $52.07 thousand -93.9%N/A3.5 $74.38 12/31/202111,400 shares $712.50 thousand -51.9%N/A10.4 $62.50 12/15/202123,700 shares $1.40 million +115.5%N/A79 $59.10 11/30/202111,000 shares $718.08 thousand +20.9%N/A22 $65.28 11/15/20219,100 shares $650.20 thousand -14.2%N/A7.6 $71.45 10/29/202110,600 shares $827.33 thousand +1.0%N/A21.2 $78.05 10/15/202110,500 shares $856.80 thousand +707.7%N/A52.5 $81.60 9/30/20211,300 shares $118.24 thousand -86.0%N/A13 $90.95 9/15/20219,300 shares $876.25 thousand -88.5%N/A46.5 $94.22Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 8/31/202180,900 shares $7.12 million -28.3%N/A404.5 $88.05 8/13/2021112,900 shares $9.71 million -21.7%N/A1129 $86.00 7/30/2021144,200 shares $12.33 million -17.2%N/A1442 $85.48 7/15/2021174,200 shares $15.27 million -1.3%N/A1742 $87.66 6/30/2021176,400 shares $16.65 million -10.2%N/A882 $94.36 6/15/2021196,500 shares $18.94 million -2.8%N/A491.3 $96.39 5/28/2021202,100 shares $19.80 million No ChangeN/A673.7 $97.96 5/14/2021202,100 shares $20.01 million +6.1%N/A673.7 $99.00 4/30/2021190,500 shares $22.67 million +1.4%N/A381 $119.00 4/15/2021187,800 shares $21.17 million +6.0%N/A626 $112.70 3/31/2021177,200 shares $19.92 million +117.2%N/A295.3 $112.40 3/15/202181,600 shares $10.18 million +6.8%N/A74.2 $124.75 2/26/202176,400 shares $10.54 million +3.1%N/A84.9 $138.00 2/12/202174,100 shares $10.60 million -27.1%N/A23.9 $143.00 1/29/2021101,700 shares $12.92 million -24.1%N/A16.4 $127.00 1/15/2021169,100 shares $16.01 million -32.8%N/A140.9 $94.70 12/31/2020149,400 shares $12.95 million -11.7%N/A747 $86.65 12/15/2020169,100 shares $15.22 million -32.8%N/A140.9 $90.00 11/30/2020251,600 shares $28.93 million +17.4%N/A359.4 $115.00 11/15/2020214,400 shares $26.03 million -6.4%N/A428.8 $121.42 10/30/2020229,100 shares $29.18 million +20.8%N/A381.8 $127.35 10/15/2020189,700 shares $29.02 million +0.2%N/A632.3 $153.00 9/30/2020189,300 shares $23.66 million +0.3%N/A1893 $125.00 9/15/2020188,800 shares $23.60 million -2.4%N/A314.7 $125.00 8/31/2020193,400 shares $19.10 million +0.8%N/A967 $98.75 8/14/2020191,800 shares $18.70 million +7.2%N/A191.8 $97.50 7/31/2020178,900 shares $18.65 million -90.6%N/A57.7 $104.25 7/15/20201,894,500 shares $20.93 million +1.5%N/A222.9 $11.05 PHMMF Short Interest - Frequently Asked Questions What is Pharma Mar's current short interest? Short interest is the volume of Pharma Mar shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 4,400 shares of PHMMF short. Learn More on Pharma Mar's current short interest. What is a good short interest ratio for Pharma Mar? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHMMF shares currently have a short interest ratio of 1.0. Learn More on Pharma Mar's short interest ratio. Is Pharma Mar's short interest increasing or decreasing? Pharma Mar saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 4,400 shares, a drop of 49.4% from the previous total of 8,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pharma Mar's short interest compare to its competitors? Here is how the short interest of companies in the industry of "med - biomed/gene" compare to Pharma Mar: Cocrystal Pharma, Inc. (0.07%), CytoMed Therapeutics Limited (1.20%), Galapagos NV (2.99%), Pulmatrix, Inc. (0.84%), RegeneRx Biopharmaceuticals Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Pharma Mar stock? Short selling PHMMF is an investing strategy that aims to generate trading profit from Pharma Mar as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharma Mar? A short squeeze for Pharma Mar occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PHMMF, which in turn drives the price of the stock up even further. How often is Pharma Mar's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHMMF, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies AFFY Short Interest Data ANTH Short Interest Data COCP Short Interest Data GDTC Short Interest Data GLPG Short Interest Data MYRX Short Interest Data PZRXQ Short Interest Data PXXLF Short Interest Data PULM Short Interest Data QNNTF Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PHMMF) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma Mar Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma Mar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
